• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Diltiazem increases steady state digoxin serum levels in patients with cardiac disease.

作者信息

Andrejak M, Hary L, Andrejak M T, Lesbre J P

机构信息

Université de Picardie, Unité de Pharmacologie Clinique, Hôpital Sud, Amiens, France.

出版信息

J Clin Pharmacol. 1987 Dec;27(12):967-70. doi: 10.1002/j.1552-4604.1987.tb05598.x.

DOI:10.1002/j.1552-4604.1987.tb05598.x
PMID:3437068
Abstract

Diltiazem has been reported to decrease or not to affect digoxin elimination. The effects of diltiazem on steady state concentrations of digoxin was evaluated in eleven patients with congestive heart failure receiving this drug for at least two weeks. The mean trough digoxin was 1.11 +/- 0.18 ng/ml before the coadministration of diltiazem (180 mg/day). This concentration increased to 1.54 +/- 0.22 ng/ml after three days and to 1.54 +/- 0.23 ng/ml after seven days of coadministration (P less than 0.01). Clinically, no patient showed signs of digitalis toxicity. Creatinine clearance was unchanged. The present results show that when diltiazem is added to a regimen that includes digoxin, steady state concentrations of this glycoside may increase.

摘要

相似文献

1
Diltiazem increases steady state digoxin serum levels in patients with cardiac disease.
J Clin Pharmacol. 1987 Dec;27(12):967-70. doi: 10.1002/j.1552-4604.1987.tb05598.x.
2
A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.地尔硫䓬与硝酸异山梨酯对慢性缺血性心力衰竭患者地高辛药效学和药代动力学影响的比较
Saudi Med J. 2002 Jun;23(6):725-31.
3
The influence of diltiazem hydrochloride on trough serum digoxin concentrations.盐酸地尔硫䓬对血清地高辛谷浓度的影响。
Drug Intell Clin Pharm. 1986 Jun;20(6):500-3. doi: 10.1177/106002808602000615.
4
Effects of nifedipine and diltiazem on plasma levels and renal excretion of beta-acetyldigoxin.
Clin Pharmacol Ther. 1985 Feb;37(2):150-6. doi: 10.1038/clpt.1985.27.
5
No increase in serum digoxin concentration with high-dose diltiazem.高剂量地尔硫䓬不会使血清地高辛浓度升高。
Am J Med. 1986 Sep;81(3):425-8. doi: 10.1016/0002-9343(86)90293-7.
6
[Diltiazem and digoxin interaction. Development of digoxin plasma levels and electrocardiographic parameters in healthy subjects].[地尔硫䓬与地高辛的相互作用。健康受试者地高辛血药浓度及心电图参数的变化]
Arch Mal Coeur Vaiss. 1986 Jul;79(8):1216-20.
7
Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease.地尔硫䓬对心脏病患者地高辛肾清除率及血清浓度的影响。
Am J Cardiol. 1985 May 1;55(11):1393-5. doi: 10.1016/0002-9149(85)90511-9.
8
Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels.慢性心房颤动中低剂量和中剂量地尔硫䓬:与地高辛比较及与药物血浆水平的相关性
Am Heart J. 1988 Aug;116(2 Pt 1):385-92. doi: 10.1016/0002-8703(88)90610-2.
9
[Effect of combined treatment of diltiazem and digoxin on serum digoxin concentration].地尔硫䓬与地高辛联合治疗对血清地高辛浓度的影响
Zhonghua Nei Ke Za Zhi. 1990 Nov;29(11):646-8, 701.
10
Some observations on serum concentrations of digitoxin and digoxin.关于洋地黄毒苷和地高辛血清浓度的一些观察结果。
Jpn Heart J. 1979 Sep;20(5):623-9. doi: 10.1536/ihj.20.623.

引用本文的文献

1
Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein.伊曲康唑和地尔硫䓬对P-糖蛋白底物非索非那定药代动力学的影响。
Br J Clin Pharmacol. 2006 May;61(5):538-44. doi: 10.1111/j.1365-2125.2006.02613.x.
2
Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.地高辛在日本患者中的群体药代动力学:二室药代动力学模型
Clin Pharmacokinet. 2001;40(10):773-81. doi: 10.2165/00003088-200140100-00005.
3
Diltiazem. A review of its pharmacology and therapeutic use in older patients.
地尔硫䓬。老年患者药理学及治疗应用综述。
Drugs Aging. 1993 Jul-Aug;3(4):363-90. doi: 10.2165/00002512-199303040-00007.
4
Cardiac glycosides. Drug interactions of clinical significance.强心苷。具有临床意义的药物相互作用。
Drug Saf. 1995 Feb;12(2):97-109. doi: 10.2165/00002018-199512020-00003.
5
Pharmacokinetic interactions with digoxin.与地高辛的药代动力学相互作用。
Clin Pharmacokinet. 1988 Oct;15(4):227-44. doi: 10.2165/00003088-198815040-00003.
6
Diltiazem. A reappraisal of its pharmacological properties and therapeutic use.地尔硫䓬。对其药理特性和治疗用途的重新评估。
Drugs. 1990 May;39(5):757-806. doi: 10.2165/00003495-199039050-00009.
7
Drug interactions in hypertensive patients. Pharmacokinetic, pharmacodynamic and genetic considerations.高血压患者的药物相互作用。药代动力学、药效学及遗传学考量
Clin Pharmacokinet. 1990 Apr;18(4):295-317. doi: 10.2165/00003088-199018040-00003.
8
Pharmacokinetic interactions with calcium channel antagonists (Part II).与钙通道拮抗剂的药代动力学相互作用(第二部分)。
Clin Pharmacokinet. 1991 Dec;21(6):448-60. doi: 10.2165/00003088-199121060-00005.
9
Calcium antagonists in patients with heart failure. A review.心力衰竭患者中的钙拮抗剂。综述。
Drugs. 1991 Sep;42(3):343-64. doi: 10.2165/00003495-199142030-00002.